Segall Bryant & Hamill, LLC Insmed Inc Transaction History
Segall Bryant & Hamill, LLC
- $6.86 Billion
- Q2 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Insmed Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 119,136 shares of INSM stock, worth $19.2 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
119,136
Previous 170,859
30.27%
Holding current value
$19.2 Million
Previous $13 Million
8.02%
% of portfolio
0.17%
Previous 0.21%
Shares
5 transactions
Others Institutions Holding INSM
# of Institutions
584Shares Held
203MCall Options Held
2.84MPut Options Held
3.26M-
Darwin Global Management, Ltd. St. Helier, Y919.3MShares$3.12 Billion82.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$2.85 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.3 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$1.81 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$1.24 Billion7.87% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $21.9B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...